Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Up 45.0% in September

Aspira Women’s Health Inc. (NASDAQ:AWH) was the recipient of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 379,300 shares, an increase of 45.0% from the August 31st total of 261,600 shares. Currently, 3.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 123,400 shares, the short-interest ratio is presently 3.1 days.

Aspira Women’s Health Stock Down 0.9 %

Shares of AWH stock traded down $0.01 on Friday, hitting $0.81. The stock had a trading volume of 54,022 shares, compared to its average volume of 69,657. The business has a 50 day moving average price of $1.08 and a 200 day moving average price of $2.04. The company has a market cap of $13.07 million, a PE ratio of -0.57 and a beta of 1.48. Aspira Women’s Health has a one year low of $0.74 and a one year high of $6.01.

Aspira Women’s Health (NASDAQ:AWH) last announced its earnings results on Monday, August 12th. The company reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.04. The firm had revenue of $2.42 million during the quarter, compared to the consensus estimate of $2.60 million. During the same quarter in the prior year, the firm posted ($0.28) earnings per share. Equities research analysts expect that Aspira Women’s Health will post -1.26 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on AWH shares. StockNews.com upgraded shares of Aspira Women’s Health from a “sell” rating to a “hold” rating in a research report on Tuesday. Alliance Global Partners reduced their price target on shares of Aspira Women’s Health from $7.00 to $5.50 and set a “buy” rating on the stock in a research report on Wednesday, August 14th.

Institutional Investors Weigh In On Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. grew its stake in Aspira Women’s Health Inc. (NASDAQ:AWH) by 43.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 179,371 shares of the company’s stock after purchasing an additional 53,997 shares during the period. B. Riley Wealth Advisors Inc. owned about 1.73% of Aspira Women’s Health worth $732,000 at the end of the most recent quarter. 12.19% of the stock is owned by hedge funds and other institutional investors.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.